The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells
- PMID: 12473608
The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells
Abstract
We assessed the ability of cryptophycin 52 (LY355703), a novel antimicrotubule, to induce growth arrest and apoptosis in prostate cancer cell lines and investigated potential molecular mechanisms of death. LNCaP (androgen-dependent) and DU-145 (androgen-independent) cells accumulated in G(2)-M phase of the cell cycle and progressively acquired sub-G(0)-G(1) DNA content after 48 h of exposure to cryptophycin 52 (1-10 pM). Induction of apoptosis was confirmed by DNA ladder formation and detection of cytoplasmic nucleosomes. PC-3 (androgen-independent) cells were less responsive to cryptophycin 52-induced death. Apoptosis was associated with proteolytic processing and activation of the caspase-3-like subfamily proteins caspase-3 and caspase-7 and cleavage of the caspase substrate poly(ADP-ribose) polymerase. The pan-caspase inhibitor BOC-Asp(OMe)-fluoromethylketone effectively reduced cryptophycin 52-induced caspase-3-like protease activity and apoptosis in DU-145 cells. In contrast, BOC-Asp(OMe)-fluoromethylketone did not inhibit apoptosis induction in LNCaP cells by cryptophycin 52, even though both cryptophycin 52-induced caspase-3-like activity and staurosporine-induced death were blocked under identical conditions. Cryptophycin 52 induced phosphorylation of c-raf1 and bcl-2 and/or bcl-x(L) to comparable levels in all cell lines studied, and LNCaP cells overexpressing bcl-2 were more resistant to cryptophycin 52-induced apoptosis. Up-regulation of p53, bax, and p21 expression was induced in wild-type p53-expressing LNCaP cells only after cryptophycin 52 exposure. A sustained increase in c-Jun NH(2)-terminal kinase phosphorylation was also observed, the levels of which strongly correlated with apoptosis. We conclude that apoptosis induced by cryptophycin 52 in prostate cancer cells is androgen status independent, cell type specific for caspase requirement, modulated by the bcl-2 family, linked to but not dependent on p53, and strongly correlated with c-Jun NH(2)-terminal kinase phosphorylation. Cryptophycin 52-induced apoptosis in prostate cancer cells is therefore associated with multiple cell line-specific alterations in apoptosis-associated proteins and pathways.
Similar articles
-
C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.Oncogene. 2002 Feb 7;21(7):1017-27. doi: 10.1038/sj.onc.1205167. Oncogene. 2002. PMID: 11850819
-
Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor.Oncogene. 2007 Feb 1;26(5):652-61. doi: 10.1038/sj.onc.1209830. Epub 2006 Aug 7. Oncogene. 2007. PMID: 16909121
-
Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53.Cancer Res. 1999 Oct 1;59(19):4848-56. Cancer Res. 1999. PMID: 10519395
-
Nitric oxide as a bioregulator of apoptosis.Biochem Biophys Res Commun. 2001 Apr 20;282(5):1075-9. doi: 10.1006/bbrc.2001.4670. Biochem Biophys Res Commun. 2001. PMID: 11302723 Review.
-
The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review.Cancer Chemother Pharmacol. 1999;44(5):355-61. doi: 10.1007/s002800050989. Cancer Chemother Pharmacol. 1999. PMID: 10501907 Review.
Cited by
-
Mitogen Activated Protein kinase signal transduction pathways in the prostate.Cell Commun Signal. 2004 Jun 25;2(1):5. doi: 10.1186/1478-811X-2-5. Cell Commun Signal. 2004. PMID: 15219238 Free PMC article.
-
Therapeutic Potential of Plant- and Marine-Derived Bioactive Compounds in Prostate Cancer: Mechanistic Insights and Translational Applications.Pharmaceuticals (Basel). 2025 Feb 20;18(3):286. doi: 10.3390/ph18030286. Pharmaceuticals (Basel). 2025. PMID: 40143065 Free PMC article. Review.
-
Therapeutic Potential of Marine Peptides in Prostate Cancer: Mechanistic Insights.Mar Drugs. 2022 Jul 22;20(8):466. doi: 10.3390/md20080466. Mar Drugs. 2022. PMID: 35892934 Free PMC article. Review.
-
New Drugs from the Sea: Pro-Apoptotic Activity of Sponges and Algae Derived Compounds.Mar Drugs. 2019 Jan 7;17(1):31. doi: 10.3390/md17010031. Mar Drugs. 2019. PMID: 30621025 Free PMC article. Review.
-
Marine Natural Products with Activities against Prostate Cancer: Recent Discoveries.Int J Mol Sci. 2023 Jan 11;24(2):1435. doi: 10.3390/ijms24021435. Int J Mol Sci. 2023. PMID: 36674949 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous